Radio-frequency thermal albation (RTFA) of small hepatocellular carcinoma in patients with cirrhosis: Experience at a single tertiary referral centre

Minerva Gastroenterologica e Dietologica

Volumn 51, Issue 2, 2005, Pages 171-178

  Licata, A ^a,c   Di Marco, V ^a   Parisi, P ^a   Latteri, F ^a   Nebbia, M E ^a   Cabibbo, G ^a   Di Bona, D ^a,b   Prinzi, G ^a   Li Petri, S ^a   Sandonato, L ^a   Latteri, M A ^a   Craxi A ^a   Camma C ^a,b  

^a UNIVERSITY OF PALERMO   (Italy)

^b CNR Consiglio Nazionale delle Ricerche   (Italy)

^c Istituto di Clinica Medica   (Italy)

Author keywords

Hepatocellular carcinoma; Liver cirrhosis; Radiofrequency thermal ablation

Indexed keywords

ADULT; AGED; ANALGESIA; ARTICLE; BURN; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; FEMALE; FEVER; FOLLOW UP; HEMATOMA; HUMAN; HUMAN CELL; KAPLAN MEIER METHOD; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER INJURY; MALE; PAIN; PLEURA EFFUSION; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR VOLUME; CANCER CENTER; CATHETER ABLATION; DISEASE FREE SURVIVAL; HYPERTHERMIC THERAPY; ITALY; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; SURVIVAL;

AGED; CANCER CARE FACILITIES; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; ITALY; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 26944474864     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-6.
2. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003;362:1907-17.
3. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999;30:1434-40.
4. Lippman SM, Hong WK. Cancer prevention by delay. Commentary re: J. A. O'Shaughnessy et al., Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development. Clin Cancer Res 2002;8:305-13.
5. Sporn MB, Dunlop NM, Newton DL, Smith JM. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc 1976;35:1332-8.
6. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993;24;328:1797-801.
7. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK et al. EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 2001;35:421-30.
8. Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003;228:235-40.
9. Shi-Ming L, Chun-Jung L, Chen-Chun L, Chao-Wei H, Yi-Cheng C. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤4 cm. Gastroenterology 2004;127: 1714-23.
10. C Cammà, V Di Marco, A Orlando, L Sandonato, A Casaril, P Parisi et al. Unità Interdipartimentale Neoplasie Epatiche (U.I.N.E) Group. Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study. Journal Hepatol in press.
11. Kaplan EI, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-81.
12. SAS Technical Report, SAS/STAS software: changes and enhancement, release 6.07. Cary, NC: SAS Institute Inc, 1992.
13. Orlando A, D'Antoni A, Camma C, Albanese M, Livraghi T, Torzilli G et al. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection: a validated prognostic model. Am J Gastroenterol 2000;95:2921-7.
14. Giovannini M, Moutardier V, Danisi C, Bories E, Pesenti C, Delpero JR. Treatment of hepatocellular carcinoma using percutaneous radiofrequency thermoablation: results and outcomes in 56 patients. J Gastrointest Surg 2003;7:791-6.
15. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999;210:655-61.
16. Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N Engl J Med 1996;334:1561-7.
17. Lau WY, Leung TW, Ho SK, Chan M, Machin D, Lau J et al. Adjuvant intra-arterial iodine-131-labelled lipiodol for respectable hepatocellular carcinoma: a prospective randomized trial. Lancet 1999;353:797-801.
18. Takayama T, Sekine T, Makuuchi M, Yamasaki S, Kosuge T, Yamamoto J et al. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomized trial. Lancet 2000;356: 802-7.
19. Ikeda K, Arase Y, Saitoh S, Kobayashi M, Suzuki Y, Suzuki F et al. Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor - a prospective randomized study of hepatitis C virus related liver cancer. Hepatology 2000;32:228-32.
20. Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Shuto T, Kinoshita H. Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy. Br J Surg 2002;89:418-22.
21. Suou T, Mitsuda A, Koda M, Matsuda H, Maruyama S, Tanaka H et al. Interferon alpha inhibits intrahepatic recurrence in hepatocellular carcinoma with chronic hepatitis C: a pilot study. Hepatol Res 2001;20:301-11.
22. Miyaguchi S, Watanabe T, Takahashi H, Nakamura M, Saito H, Ishii H. Interferon therapy for hepatocellular carcinoma patients with low HCV-RNA levels. Hepatogastroenterology 2002;49:724-9.
23. Shiratori Y, Shiina S, Teratani T, Imamura M, Obi S, Sato S et al. Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus. Ann Intern Med 2003;138:299-306.
24. Cammà C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trial. Radiology 2002;224:47-54.
25. Llovet JM, Vilana R, Bru C, Bianchi L, Salmeron JM, Boix L et al.; Barcelona Clinic Liver Cancer (BCLC) Group. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001;33:1124-9.
26. Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation:complications encountered in a multicenter study. Radiology 2003;226: 441-51.
27. Neeman Z, Libutti SK, Patti JW, Wood BJ. Percutaneous radiofrequency ablation of hepatocellular carcinoma in the presence of portal vein thrombosis. Clin Imaging 2003;27:417-20.